Applied Therapeutics Inc (APLT)
4.71
-0.11
(-2.28%)
USD |
NASDAQ |
May 08, 16:00
4.72
+0.01
(+0.21%)
After-Hours: 20:00
Applied Therapeutics Net Income (Quarterly): -37.68M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -37.68M |
September 30, 2023 | -42.37M |
June 30, 2023 | -29.58M |
March 31, 2023 | -10.14M |
December 31, 2022 | -14.43M |
September 30, 2022 | -19.10M |
June 30, 2022 | -25.86M |
March 31, 2022 | -23.12M |
December 31, 2021 | -27.16M |
September 30, 2021 | -28.42M |
June 30, 2021 | -25.83M |
March 31, 2021 | -24.18M |
Date | Value |
---|---|
December 31, 2020 | -23.69M |
September 30, 2020 | -29.84M |
June 30, 2020 | -28.06M |
March 31, 2020 | -12.37M |
December 31, 2019 | -17.63M |
September 30, 2019 | -10.71M |
June 30, 2019 | -8.437M |
March 31, 2019 | -8.73M |
December 31, 2018 | -6.719M |
September 30, 2018 | -4.281M |
June 30, 2018 | -3.185M |
March 31, 2018 | -2.335M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-42.37M
Minimum
Sep 2023
-8.437M
Maximum
Jun 2019
-23.08M
Average
-24.18M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 36.12M |
Fate Therapeutics Inc | -44.12M |
Viking Therapeutics Inc | -27.36M |
Terns Pharmaceuticals Inc | -21.02M |
Edgewise Therapeutics Inc | -30.14M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | -0.667M |
Total Expenses (Quarterly) | 20.34M |
EPS Diluted (Quarterly) | -0.33 |
Enterprise Value | 449.14M |
Earnings Yield | -28.66% |
Normalized Earnings Yield | -15.75 |